Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-055368

Chief Financial Officer sold 14,375 shares at an average $39.47 ($567,331)

  • Chief Financial Officer acquired 14,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Chad M · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-07 Exercise or conversion : show line 1 in the form +9,375 $6.55 $61,406 30,979 D
2021-09-07 Sale : show line 2 in the form −9,375 $39.71 $372,281 21,604 D
2021-09-08 Exercise or conversion : show line 3 in the form +5,000 $7.27 $36,350 26,604 D
2021-09-08 Sale : show line 4 in the form −5,000 $39.01 $195,050 21,604 D
Open-market sales · 14,375 sh · avg $39.47 · $567,331

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-09-07 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −9,375 65,625 D
2021-09-08 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −5,000 110,000 D
Loading xslF345X03/doc4.xml…